Accueil>>Signaling Pathways>> Neuroscience>> Dopamine Receptor>>Pericyazine

Pericyazine (Synonyms: Propericiazine, RP 8909, SKF 20,716)

Catalog No.GC38231

La péricyazine (propériciazine) est un agent antipsychotique de première génération utilisé en complément de la prise en charge À court terme des états anxieux sévères et de la psychose.

Products are for research use only. Not for human use. We do not sell to patients.

Pericyazine Chemical Structure

Cas No.: 2622-26-6

Taille Prix Stock Qté
1mg
52,00 $US
En stock
5mg
102,00 $US
En stock
10mg
173,00 $US
En stock
25mg
347,00 $US
En stock
50mg
581,00 $US
En stock
100mg
979,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Pericyazine (Propericiazine) is a first-generation antipsychotic drug that is used as an adjunct to the short-term management of severe anxiety states and psychosis[1]. Pericyazine (Propericiazine) is a selective D2-dopamine receptor antagonist[2][3].

[1]. Morley KC, et al. Pericyazine in the treatment of cannabis dependence in general practice: a naturalistic pilot trial. Subst Abuse Rehabil. 2012 May 28;3:43-7. [2]. Farde L, et al. D1- and D2-dopamine receptor occupancy during treatment with conventional and atypicalneuroleptics. Psychopharmacology (Berl). 1989;99 Suppl:S28-31. [3]. Divac N, et al. Second-generation antipsychotics and extrapyramidal adverse effects. Biomed Res Int. 2014;2014:656370.

Avis

Review for Pericyazine

Average Rating: 5 ★★★★★ (Based on Reviews and 16 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Pericyazine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.